Parsons Elizabeth C, Carter John C, Wrede Joanna E, Donovan Lucas M, Palen Brian N
Division of Pulmonary, Critical Care and Sleep Medicine, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA.
Division of Pulmonary, Critical Care, and Sleep Medicine, Case Western Reserve University School of Medicine and MetroHealth, Cleveland, OH.
Can J Respir Ther. 2019 Jan 9;55:13-15. doi: 10.29390/cjrt-2018-020. eCollection 2019.
Noninvasive ventilation (NIV) may improve survival and quality of life in Amyotrophic Lateral Sclerosis (ALS) patients. There is a surprising paucity of practical guidelines for office-based implementation and management of NIV outside of tertiary ALS centers. We saw the need for a clinical protocol to allow feasible and consistent NIV management in this patient population.
We created a clinical protocol for office-based initiation of NIV implemented on consecutive ALS patients referred from our regional ALS multidisciplinary clinic. The protocol provided initial empiric settings using a bilevel device in volume-assured pressure support mode. A respiratory therapist (RT) initiated NIV in an office setting and made adjustments according to patient tolerance and therapy targets outlined in the protocol. Later setting changes were performed at patient or provider request. We evaluated patient adherence and efficacy via device download at 30 days and 1 year.
We present data from a case series of the first 14 consecutive patients initiated on NIV over a 20-month period. Our protocol underwent iterative modification based on clinical experience and patient feedback. Early challenges included the significant time and resource burden required to coordinate device downloads and patient follow-up. Early 30-day NIV adherence was variable (median 20 out of 30 days), while 1-year NIV adherence was excellent (median 27.5 out of 30 days).
Our RT-driven clinical NIV protocol was feasible but labor intensive. Achieving real-world adherence of NIV in our ALS patients required iterative protocol adjustment, significant RT provider time, and tele-based follow-up.
无创通气(NIV)可能改善肌萎缩侧索硬化症(ALS)患者的生存率和生活质量。在三级ALS中心之外,针对门诊实施和管理NIV的实用指南出奇地匮乏。我们认为需要一个临床方案,以便在这一患者群体中进行可行且一致的NIV管理。
我们制定了一个针对门诊启动NIV的临床方案,该方案应用于从我们地区ALS多学科诊所转诊来的连续ALS患者。该方案采用容量保证压力支持模式的双水平设备提供初始经验设置。一名呼吸治疗师(RT)在门诊环境中启动NIV,并根据患者耐受性和方案中概述的治疗目标进行调整。后续的设置更改根据患者或提供者的要求进行。我们通过在30天和1年时下载设备数据来评估患者的依从性和疗效。
我们展示了一个病例系列的数据,该系列为在20个月期间连续接受NIV治疗的前14例患者。我们的方案根据临床经验和患者反馈进行了迭代修改。早期面临的挑战包括协调设备下载和患者随访所需的大量时间和资源负担。30天早期NIV依从性参差不齐(30天中值为20天),而1年NIV依从性良好(30天中值为27.5天)。
我们由RT驱动的临床NIV方案可行,但劳动强度大。要在我们的ALS患者中实现NIV在现实中的依从性,需要对方案进行迭代调整、RT提供者投入大量时间以及进行远程随访。